News
02-18-2016, 05:40 AM
People with Merkel cell, gynecological, gastric and head and neck cancers may be eligible to participate in a clinical trial at Sanford Health testing the effectiveness of an investigational drug called nivolumab.
More... (http://www.news-medical.net/news/20160218/Sanford-Health-clinical-trial-testing-effectiveness-of-investigational-cancer-drug-nivolumab.aspx)
More... (http://www.news-medical.net/news/20160218/Sanford-Health-clinical-trial-testing-effectiveness-of-investigational-cancer-drug-nivolumab.aspx)